CSPC Innovation Pharmaceutical (300765.SZ) Earnings Analysis

CSPC Innovation Pharmaceutical (300765.SZ) next reports earnings on 2026-08-18. Trailing P/E -180.08.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300765.SZ next report earnings?

Next earnings date2026-08-18
Consensus EPS estimaten/a
Revenue estimate0.67B

300765.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-27-0.0674 CNYn/an/an/a
2026-03-17-0.15 CNYn/an/an/a
2025-10-27-0.0153 CNYn/an/an/a
2025-08-150.01735 CNYn/an/an/a
2025-03-20-0.0613 CNYn/an/an/a
2024-10-230.00165 CNYn/an/an/a
2024-08-160.04151 CNYn/an/an/a

300765.SZ valuation and analyst view

Trailing P/E-180.08
Trailing EPS-0.22123 CNY
Price / book20.86
Dividend yield0.00%
Market cap55.82B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is CSPC Innovation Pharmaceutical (300765.SZ)'s next earnings date?

CSPC Innovation Pharmaceutical is next scheduled to report on 2026-08-18 and revenue estimate of 0.67B.

Did 300765.SZ beat earnings last quarter?

Consensus estimate data was not available for 300765.SZ's 2026-04-27 report.

What is 300765.SZ's current P/E ratio and EPS?

300765.SZ trades at a trailing P/E of -180.08 on trailing EPS of -0.22122683523810668 CNY.

What do analysts rate 300765.SZ?

300765.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.